Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses

Tigilanol tiglate is a novel small molecule approved as a veterinary pharmaceutical in Europe for intratumoural treatment of non-metastatic, non-resectable canine mast cell tumors. The drug has a “tumor agnostic” mode of action associated with induction of an acute inflammatory response at the treat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Vet Sci
Hlavní autoři: De Ridder, Thomas, Ruppin, Mick, Wheeless, Meagan, Williams, Stephanie, Reddell, Paul
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Veterinary Science
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509040/
https://ncbi.nlm.nih.gov/pubmed/33033726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fvets.2020.00639
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky